Historical record - last NADAC effective date: 9/20/2023

Product Information

AMLODIPINE-ATORVAST 10-10 MG is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $1.2757 per EA under NDC 43598032130. Its NADAC has been published 490 times since May 14, 2014.

FDA first approved this application on Mar 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-ATORVAST 10-10 MG

Amlodipine besylate and Atorvastatin calcium
$1.2757per EA

Strength

10; 10 mg/1; mg/1

NDC

43598032130

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

9/20/2023

Approval Type

Generic (ANDA)

FDA Application

ANDA203874

FDA Approved

3/7/2014

TE Code

AB

On Market Since

3/17/2014

Pharmacological Classes

Calcium Channel Antagonists
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for AMLODIPINE-ATORVAST 10-10 MG has been published 490 times since May 14, 2014, and over the history we have for it it has declined 70.1%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2757 per EA
All-time high$5.1337 (Jul 15, 2015)
All-time low$1.0931 (Dec 21, 2022)
Median price$3.0535
Average price$3.0192
Largest weekly change+65.6% (Feb 22, 2023)
Weeks tracked490
Tracking sinceMay 14, 2014

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-34.0%

5Y

-35.4%

All

-70.1%

Last surveyed Sep 27, 2023 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-ATORVAST 10-10 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 10-10 MG, manufactured by Dr. Reddy's Laboratories Inc., is $1.2757 per EA (NDC 43598032130), effective Sep 27, 2023.

How has the price of AMLODIPINE-ATORVAST 10-10 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 10-10 MG has declined 70.1%. It has been tracked across 490 weekly CMS publications since May 14, 2014.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 10-10 MG?

Since May 14, 2014, the NADAC for AMLODIPINE-ATORVAST 10-10 MG has ranged from a low of $1.0931 (Dec 21, 2022) to a high of $5.1337 (Jul 15, 2015), with a median of $3.0535 per EA.

Are there cheaper alternatives to AMLODIPINE-ATORVAST 10-10 MG?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 10-10 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-ATORVAST 10-10 MG?

AMLODIPINE-ATORVAST 10-10 MG (NDC 43598032130) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.